Combination immunotherapy and vaccines in cancer

Dr. Wei Xu of the Roche Innovation Center discusses the use of combination immunotherapy to increase priming and activation, antigen presentation and recognition of cancer cells. He used an MHC Class I Pentamer to show cancer-specific immunity and expansion of CD8 T cells in response to DNA vaccine plus immunotherapy.